BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19151749)

  • 1. The protein-tyrosine kinase Syk interacts with TRAF-interacting protein TRIP in breast epithelial cells.
    Zhou Q; Geahlen RL
    Oncogene; 2009 Mar; 28(10):1348-56. PubMed ID: 19151749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase.
    Takada Y; Mukhopadhyay A; Kundu GC; Mahabeleshwar GH; Singh S; Aggarwal BB
    J Biol Chem; 2003 Jun; 278(26):24233-41. PubMed ID: 12711606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6.
    Wu NL; Huang DY; Tsou HN; Lin YC; Lin WW
    J Invest Dermatol; 2015 Feb; 135(2):490-498. PubMed ID: 25202827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNF activates Syk protein tyrosine kinase leading to TNF-induced MAPK activation, NF-kappaB activation, and apoptosis.
    Takada Y; Aggarwal BB
    J Immunol; 2004 Jul; 173(2):1066-77. PubMed ID: 15240695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
    Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
    J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by Syk of Bcl-2, calcium and the calpain-calpastatin proteolytic system in human breast cancer cells.
    Fei B; Yu S; Geahlen RL
    Biochim Biophys Acta; 2013 Oct; 1833(10):2153-64. PubMed ID: 23684705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetramethylpyrazine attenuates TNF-α-induced iNOS expression in human endothelial cells: Involvement of Syk-mediated activation of PI3K-IKK-IκB signaling pathways.
    Zheng Z; Li Z; Chen S; Pan J; Ma X
    Exp Cell Res; 2013 Aug; 319(14):2145-51. PubMed ID: 23726836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic acid regulates spleen tyrosine kinase to repress tumour necrosis factor-alpha-induced monocyte chemotatic protein-1 production in cultured human aortic endothelial cells.
    Koo TY; Kim YJ; Yang WS; Park JS; Han NJ; Lee JM; Park SK
    Cell Biol Int; 2013 Jan; 37(1):19-28. PubMed ID: 23319318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
    Mahabeleshwar GH; Kundu GC
    J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.
    Chakraborty G; Rangaswami H; Jain S; Kundu GC
    J Biol Chem; 2006 Apr; 281(16):11322-31. PubMed ID: 16474166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages.
    Sun H; Xu XY; Tian XL; Shao HT; Wu XD; Wang Q; Su X; Shi Y
    Immunobiology; 2014 Jan; 219(1):25-36. PubMed ID: 23886693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factor.
    Regamey A; Hohl D; Liu JW; Roger T; Kogerman P; Toftgard R; Huber M
    J Exp Med; 2003 Dec; 198(12):1959-64. PubMed ID: 14676304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Piceatannol inhibits TNF-induced NF-kappaB activation and NF-kappaB-mediated gene expression through suppression of IkappaBalpha kinase and p65 phosphorylation.
    Ashikawa K; Majumdar S; Banerjee S; Bharti AC; Shishodia S; Aggarwal BB
    J Immunol; 2002 Dec; 169(11):6490-7. PubMed ID: 12444159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High glucose-induced NF-kappaB activation occurs via tyrosine phosphorylation of IkappaBalpha in human glomerular endothelial cells: involvement of Syk tyrosine kinase.
    Yang WS; Seo JW; Han NJ; Choi J; Lee KU; Ahn H; Lee SK; Park SK
    Am J Physiol Renal Physiol; 2008 May; 294(5):F1065-75. PubMed ID: 18353872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN.
    Heyninck K; De Valck D; Vanden Berghe W; Van Criekinge W; Contreras R; Fiers W; Haegeman G; Beyaert R
    J Cell Biol; 1999 Jun; 145(7):1471-82. PubMed ID: 10385526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-1 induced chemokine production through the association of Syk with TNF receptor-associated factor-6 in nasal fibroblast lines.
    Yamada T; Fujieda S; Yanagi S; Yamamura H; Inatome R; Yamamoto H; Igawa H; Saito H
    J Immunol; 2001 Jul; 167(1):283-8. PubMed ID: 11418661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
    Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
    Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tyrosine kinase Syk regulates TPL2 activation signals.
    Eliopoulos AG; Das S; Tsichlis PN
    J Biol Chem; 2006 Jan; 281(3):1371-80. PubMed ID: 16291755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulatory role of Syk gene on vascular endothelial growth factor C expression in breast cancer].
    Chen XL; Li L; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):805-9. PubMed ID: 22336204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activation.
    Lee SY; Lee SY; Choi Y
    J Exp Med; 1997 Apr; 185(7):1275-85. PubMed ID: 9104814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.